[Brainlife] Cyclophosphamide

Treatment > Cyclophosphamide

Germ Cell Tumors

	Kellie SJ, Boyce H, Dunkel IJ, Diez B, Rosenblum M, Brualdi L, Finlay JL Primary chemotherapy for intracranial nongerminomatous germ cell tumors: results of the second international CNS germ cell study group protocol J Clin Oncol. 2004 Mar 1;22(5):846-53.

Glioblastoma

	Chamberlain MC, Tsao-Wei DD Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme Cancer. 2004 Mar 15;100(6):1213-20.

Gliomas

	A. Desjardins, J. A. Quinn, D. A. Reardon, J. N. Rich, J. J. Vredenburgh, C. Efird, H. S. Friedman Phase II study of thalidomide and daily cyclophosphamide for adults with malignant glioma 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1554
	Friedman HS, Keir S, Pegg AE, Houghton PJ, Colvin OM, Moschel RC, Bigner DD, Dolan ME O6-benzylguanine-mediated enhancement of chemotherapy Mol Cancer Ther 2002 Sep;1(11):943-8

Gliomas (High-Grade)

	Dufour C, Grill J, Lellouch-Tubiana A, Puget S, Chastagner P, Frappaz D, Doz F, Pichon F, Plantaz D, Gentet JC, Raquin MA, Kalifa C. High-grade glioma in children under 5 years of age: A chemotherapy only approach with the BBSFOP protocol. Eur J Cancer. 2006 Sep 6; [Epub ahead of print] Abstract

Gliomas (Low-Grade)

	Mee Jeong Lee, Young Shin Ra, Jun Bum Park, Hyun Woo Goo, Seung Do Ahn, Shin Kwang Khang, Joon Sup Song, Yoon Jung Kim and Thad T. Ghim Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children Journal of Neuro-Oncology, Volume 80, Number 3 / December, 2006, Pages 277-284, Published online: 29 June 2006

Malignant Lymphoma

	Brian Patrick O'Neill, Judith Rich O'Fallon, Stephen S Cha, Paul J Kurtin, Bernd W Scheithauer, Paul D Brown, Thomas A Habermann, Fernando K Addo, Mark Gilbert Newly diagnosed primary central nervous system lymphoma (PCNSL): initial report of North Central Cancer Treatment Group (NCCTG)/Eastern Cooperative Oncology Group (ECOG) protocol 93 73 51 38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. 2074

Medulloblastoma

	Alba A Brandes, Mario Ermani, Pietro Amista, Umberto Basso, Francesca Vastola, Antonino Rotilio, Carlo Mazza, Franco Ammannati, Bianca Guglielmi, Franco Berti A prospective study on medulloblastoma (MB) in adults 38th ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. Abstract No. 301
	Dr, Prof Amar Gajjar MD, Murali Chintagumpala MD, David Ashley MBBS, Stewart Kellie MBBS, Prof Larry E Kun MD, Prof Thomas E Merchant DO, Shaio Woo MD, Greg Wheeler MBBS, Valerie Ahern MBBS, Matthew J Krasin MD, Maryam Fouladi MD, Alberto Broniscer MD, Prof Robert Krance MD, Gregory A Hale MD, Clinton F Stewart PharmD, Robert Dauser MD, Prof Robert A Sanford MD, Christine Fuller MD, Ching Lau MD, Prof James M Boyett PhD, Dana Wallace MS and Richard J Gilbertson MD Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial Lancet Oncology Early Online Publication, 7 September 2006, DOI:10.1016/S1470-2045(06)70867-1 Abstract / BrainLife \| News / News

Metastatic Tumors

	Colleoni M, Rocca A, Sandri MT, Zorzino L, Masci G, Nole F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de BF, Viale G, Goldhirsch A Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels Ann Oncol 2002 Jan;13(1):73-80
	Laura Orlando, Anna Cardillo, Raffaella Ghisini, Andrea Rocca, Alessandra Balduzzi, Rosalba Torrisi, Giulia Peruzzotti, Aron Goldhirsch, Elisabetta Pietri, and Marco Colleoni Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer BMC Cancer. 2006 Sep 15;6:225 Abstract \| Full Text \| Reprint

Neuroblastoma

	A. Donfrancesco, A. Jenkner, A. Castellano, I. Ilari, G. M. Milano, C. Dominici, L. De Sio, P. Fidani Front-line topotecan and high-dose cyclophosphamide followed by ICE in high-risk neuroblastoma 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8536
	C. N. Frantz, W. B. London, L. Diller, R. Seeger, K. Sawyer Recurrent neuroblastoma: Randomized treatment with topotecan + cyclophosphamide (T+C) vs. topotecan alone(T). A POG/CCG Intergroup Study 40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.8512
	H Rubie, C Coze, D Plantaz, C Munzer, A S Defachelles, C Bergeron, C Thomas, P Chastagner, D Valteau-Couanet, J Michon, V Mosseri and O Hartmann Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy British Journal of Cancer3 November 2003, Volume 89, Number 9, 1605-1609

Non-Nervous System Tumors

	Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, Folkman J Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer Cancer Res 2000 Apr 1;60(7):1878-86 (PDF Full Text)
	Man S, Bocci G, Francia G, Green SK, Jothy S, Hanahan D, Bohlen P, Hicklin DJ, Bergers G, Kerbel RS Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water Cancer Res 2002 May 15;62(10):2731-5

Paraneoplastic Neur. Dis.

	Steven Vernino, Brian Patrick O’Neill, Randolph S. Marks, Judith R. O’Fallon, and David W. Kimmel Immunomodulatory treatment trial for paraneoplastic neurological disorders Neuro-Oncology, January 2004, Volume 6, Number 1, Pages: 55 -- 62 (Abstract+)

Pediatric Brain Tumors

	Maura Massimino, Lorenza Gandola, Roberto Luksch, Filippo Spreafico, Daria Riva, Carlo Solero, Felice Giangaspero, Franco Locatelli, Marta Podda, Fabio Bozzi, Emanuele Pignoli, Paola Collini, Graziella Cefalo, Marco Zecca, Michela Casanova, Andrea Ferrari, Monica Terenziani, Cristina Meazza, Daniela Polastri, Davide Scaramuzza, Fernando Ravagnani, and Franca Fossati-Bellani Sequential chemotherapy, high-dose thiotepa, circulating progenitor cell rescue, and radiotherapy for childhood high-grade glioma Neuro-Oncology, Volume 7, Number 1, Pages 41 -- 48, January 2005. (Abstract+)